Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A computational index derived from whole-genome copy number analysis is a novel tool for prognosis in early stage lung squamous cell carcinoma.
Belvedere O, Berri S, Chalkley R, Conway C, Barbone F, Pisa F, MacLennan K, Daly C, Alsop M, Morgan J, Menis J, Tcherveniakov P, Papagiannopoulos K, Rabbitts P, Wood HM. Belvedere O, et al. Genomics. 2012 Jan;99(1):18-24. doi: 10.1016/j.ygeno.2011.10.006. Epub 2011 Oct 25. Genomics. 2012. PMID: 22050995 Free article.
Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens.
Wood HM, Belvedere O, Conway C, Daly C, Chalkley R, Bickerdike M, McKinley C, Egan P, Ross L, Hayward B, Morgan J, Davidson L, MacLennan K, Ong TK, Papagiannopoulos K, Cook I, Adams DJ, Taylor GR, Rabbitts P. Wood HM, et al. Among authors: belvedere o. Nucleic Acids Res. 2010 Aug;38(14):e151. doi: 10.1093/nar/gkq510. Epub 2010 Jun 4. Nucleic Acids Res. 2010. PMID: 20525786 Free PMC article.
Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
Fasola G, Belvedere O, Aita M, Zanin T, Follador A, Cassetti P, Meduri S, De Pangher V, Pignata G, Rosolen V, Barbone F, Grossi F. Fasola G, et al. Among authors: belvedere o. Oncologist. 2007 Oct;12(10):1215-24. doi: 10.1634/theoncologist.12-10-1215. Oncologist. 2007. PMID: 17962615 Free article.
Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001).
Grossi F, Belvedere O, Fasola G, Barbone F, Rizzato S, Sibau A, Recchia L, Vigevani E, Ceschia T, Morelli A, Guglielmi A, Puglisi F, Follador A, Talmassons G, Sobrero AF. Grossi F, et al. Among authors: belvedere o. Lung Cancer. 2004 Oct;46(1):99-106. doi: 10.1016/j.lungcan.2004.03.003. Lung Cancer. 2004. PMID: 15364137 Clinical Trial.
Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F, Spizzo R, Bordo D, Cacitti V, Valent F, Rossetto C, Follador A, Di Terlizzi S, Aita M, Morelli A, Fasola G, Consiglieri C, Ceschia T, Beltrami CA, Belvedere O. Grossi F, et al. Among authors: belvedere o. J Thorac Oncol. 2010 Sep;5(9):1354-60. doi: 10.1097/JTO.0b013e3181e77a78. J Thorac Oncol. 2010. PMID: 20631638 Free article.
Lung Cancer Highlights from ASCO 2005.
Belvedere O, Grossi F. Belvedere O, et al. Oncologist. 2006 Jan;11(1):39-50. doi: 10.1634/theoncologist.11-1-39. Oncologist. 2006. PMID: 16401712 Free article.
Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007).
Grossi F, Fasola G, Rossetto C, Spizzo R, Meduri S, Sibau A, Vigevani E, Tumolo S, Adami G, Sacco C, Recchia L, Rizzato S, Ceschia T, Belvedere O. Grossi F, et al. Among authors: belvedere o. Lung Cancer. 2006 Apr;52(1):89-92. doi: 10.1016/j.lungcan.2005.11.013. Epub 2006 Feb 17. Lung Cancer. 2006. PMID: 16483688 Clinical Trial.
37 results